Southwest Oncology Group

西南肿瘤组

基本信息

批准号：
7487667
负责人：
LAWRENCE E FLAHERTY
金额：
$ 2.5万
依托单位：
WAYNE STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1978
资助国家：
美国
起止时间：
1978-01-01 至 2009-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7487667
关键词：
Academic Medical Centers Academy Address Adenovirus p53 Adherence Adjuvant Adjuvant Therapy Adverse event African American Agreement All Sites American American Association of Cancer Research American Society of Clinical Oncology Amifostine Anaplastic astrocytoma Androgen Antagonists Androgens Antithymoglobulin Appointment Area Arts Authorship Award Basic Science Biological Preservation Biology Bladder Blinded Blood Books Brain Breast Calendar Cancer Center Cancer Control Cancer Patient Carbon Dioxide Carboplatin Cardiovascular Surgical Procedures Caring Carmustine Chairperson Chemoprevention Chest Chin Cisplatin Clinic Clinical Clinical Nurse Specialists Clinical Oncology Clinical Pathology Clinical Practice Guideline Clinical Protocols Clinical Research Clinical Research Associate Clinical Trials Clinical Trials Cooperative Group Clinical Trials Database Code Color Combined Modality Therapy Communication Communities Community Clinical Oncology Program Comprehensive Cancer Center Conduct Clinical Trials Consent Consent Forms Cytogenetics Data Data Collection Data Quality Data Reporting Defective spinal cord development Dental Diagnostic Diagnostic tests Discipline Discipline of Nursing Disease Doctor of Medicine Doctor of Philosophy Documentation Dysmyelopoietic Syndromes Economics Elderly Electronic Mail Eligibility Determination Enrollment Ensure Estramustine Estramustine/Etoposide Evaluation Exercise F 4 Faculty Florida Flow Cytometry Fluorouracil Flutamide Follow-Up Studies Foundations Future GRP gene Gemcitabine/Paclitaxel Genitourinary system Geographic Locations Glioma Glutamine Goals Grant Group Meetings Guidelines Hawaii Head Head and Neck Cancer Head and neck structure Health Fairs Height Hematology Home environment Hospitals Hour Housing Human Genetics Human Resources Image Immunotherapy Individual Inpatients Institutes Institution Interferons Interleukin-4 International Internet Intervention Intranet Intravenous Investigation Investigational Drugs Japan Journals Label Laboratories Larynx Lasers Lead Leadership Life Lung Lymph Lymphoma Maintenance Malignant Neoplasms Malignant Squamous Cell Neoplasm Malignant neoplasm of lung Malignant neoplasm of prostate Manuscripts Medical Medical Oncologist Medical Oncology Medical Records Medicine Melanocytic nevus Mesothelioma Metastatic Melanoma Michigan Minority Mole the mammal Monitor Mouth Carcinoma Multiple Myeloma Names Nature Neoadjuvant Therapy New England Non-Small-Cell Lung Carcinoma Notification Numbers Nurse Administrator Nurse Practitioners Nurses Oncologic Nursing Oncology Nurse Operative Surgical Procedures Organ Oropharyngeal Outpatients Paclitaxel Pancreas Paper Participant Pathology Patient Appointment Patients Patients&apos Rooms Performance Performance Status Perioperative Personal Computers Pharmaceutical Preparations Pharmacotherapy Pharmacy facility Phase Phase II Clinical Trials Phase II/III Trial Phase III Clinical Trials Physician Assistants Physicians Physicians&apos Offices Physics Pilot Projects Placebos Play Policies Pontine structure Population Positioning Attribute Positron-Emission Tomography Preparation Principal Investigator Printing Procedures Process Progress Reports Prostate Protocols documentation Psychological reinforcement Publications Published Comment Publishing Pulmonary Tuberculosis Radiation Radiation Oncology Radiology Specialty Randomized Controlled Clinical Trials Records Recruitment Activity Recurrence Refractory Regulation Relapse Reporting Research Research Ethics Committees Research Personnel Research Priority Resectable Resources Risk Role Safety Salmon Sampling Schedule Science Secure Security Side Site Societies Solid Source Southwest Oncology Group Sparrows Squamous Cell Staging Surgical Oncologist Surgical Oncology Surgical Pathology Suspension substance Suspensions TP protocol Telefacsimile Test Result Therapeutic Therapy Clinical Trials Thoracic Oncology Time Topotecan Toxic effect Training Transfusion Translating Translational Research Translations Treatment Protocols Triage Tumor Biology United States Department of Veterans Affairs Universities University Hospitals Update Upper arm Urology Veterans Hospitals Visit Weight Withdrawal Woman Women&apos s Health Wood material Work Xoladex abstracting anticancer research awake base cancer genetics cancer research center director chemotherapy compound 351 A data management day demographics deprivation dosage expectation experience follow-up gastrointestinal gene therapy hydroxyurea interest leukemia leukemia/lymphoma lomustine/procarbazine/vincristine melanoma member meningioma multidisciplinary named group neuro-oncology novel oncology oxaliplatin pancreatic neoplasm pilot trial posters programs prospective quality assurance repository research facility research study response sarcoma statistical center symposium translational approach tumor ward

项目摘要

Wayne State University (WSU) has been an active institutional member of the Southwest Oncology Group for over 30 years, enrolling over 4000 patients onto clinical trials. Over these years, our faculty have played an important role in support of SWOG, by providing leadership in the administrative and scientific functions of SWOG, and also by meeting and exceeding patient accrual goals in a continuous and consistent manner. Thus, WSU has remained in the first quartile of institution's performance evaluation conducted by SWOG in each of the last five years. The clinical research program in cancer at WSU has been organized along the lines of multidisciplinary disease oriented studies and in a manner which resembles the organ committee orientation of SWOG. Thus, our faculty's representation in scientific SWOG committees is constituted by individuals with expertise and commitment toward those areas of research. Accordingly, the translation of ideas into SWOG studies as well as the incorporation of SWOG studies and those of NCI designated high priority trials into WSU treatment priorities, are easily facilitated. In addition, the demographics of our region and the commitment of investigators to make clinical trials available to all patients, is clearly identified in our recruitment of minorities (27%) and women (61%) into SWQG clinical trials. The SWOG membership in WSU and the diversity of disciplinary involvement by our faculty has continued to grow over the years. To date over 100 WSU members are currently serving on over 40 committees. Similarly, 50 SWOG studies list a WSU member as a study primary coordinator or co-coordinator since the last competing application was submitted. Fifth three abstracts and 56 manuscripts have had WSU faculty as primary or co-authors. Six WSU physician faculty and 3 nurses hold 14 committee administrative roles. Since the last competitive renewal WSU has been awarded NCl supplemental grants for chemoprevention and minority recruitment. Dr. Lawrence Flaherty, a SWQG member since 1986 and Vice-Chairman of the SWOG Melanoma Committee, has been the Principal Investigator since 1996 and has maintained the prominence of WSU as a SWOG member institution.

韦恩州立大学 (WSU) 是西南肿瘤学组的活跃机构成员 30 多年来，招募了 4000 多名患者参加临床试验。这些年来，我们的老师们在比赛中通过在行政和科学职能方面提供领导，在支持 SWOG 方面发挥重要作用 SWOG，以及以持续一致的方式满足并超越患者累积目标。因此，在 SWOG 进行的机构绩效评估中，WSU 一直位居前四分位。过去五年的每一年。华盛顿州立大学的癌症临床研究项目是按照以类似于器官委员会的方式进行多学科疾病导向研究 SWOG 的方向。因此，我们的教师在科学 SWOG 委员会中的代表由以下人员组成：具有专业知识并致力于这些研究领域的个人。据此，翻译将想法纳入 SWOG 研究，以及将 SWOG 研究与 NCI 指定的高水平研究相结合 WSU 治疗优先事项的优先试验很容易得到促进。此外，我们地区的人口统计数据我们的研究人员明确承诺向所有患者提供临床试验招募少数族裔 (27%) 和女性 (61%) 参加 SWQG 临床试验。 SWOG 会员资格多年来，华盛顿州立大学和我们教师参与学科的多样性不断增长。到截至目前，已有 100 多名 WSU 成员在 40 多个委员会任职。同样，50 个 SWOG 研究列表自上次竞争申请以来，WSU 成员作为研究主要协调员或联合协调员已提交。第五，三篇摘要和 56 篇手稿由 WSU 教师作为主要或共同作者。六 WSU 的医师和 3 名护士担任 14 个委员会行政职务。自从上次比赛以来续订 WSU 已获得 NCl 补充拨款，用于化学预防和少数族裔招募。 Lawrence Flaherty 博士，自 1986 年起成为 SWQG 成员，兼 SWOG 黑色素瘤组织副主席委员会，自 1996 年以来一直担任首席研究员，并保持了 WSU 作为 SWOG 成员机构。